Larvol Delta - European-regulatory-approval-obtained-to-resume-enrolment-in-the-HOVON-172-MF-study-evaluating-tasquinimod-in-myelobrosis-and-conducted-in-collaboration-between-Active-Biotech-Oncode-and-HOVON

tasquinimod (ABR-215050) - Active Biotech

https://www.tradingview.com/news/modular_finance:cbb96e440624d:0-european-regulatory-approval-obtained-to-resume-enrolment-in-the-hovon-172-mf-study-evaluating-tasquinimod-in-myelofibrosis-and-conducted-in-collaboration-between-active-biotech-oncode-and-hovon/

May 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next